Quality Investment Offering Quarterly Income

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

Accredited Investors

The Company shall be entitled to a 50% profits interest in any net profits realized by PathFree Technologies in connection with its inventions and intellectual property for a five (5) year term (the “Term”); and

At the conclusion of the Term, Members of the Company holding Convertible Common Units shall have the right and option to either:

Receive a 100% return of their Capital Contribution to the Company (a “Redemption”); or

Convert their Units into shares of voting common stock in PathFree Technologies on a 1:1 basis (a “Conversion”, i.e., 1 Unit converts into 1 share).

Notwithstanding the foregoing, at their sole option, the Manager of the Company may effect either a Redemption or a Conversion of all of the Company’s outstanding Convertible Common Units in the event PathFree Technologies enters into any merger agreement or adopts a plan in which it or its successors or assigns either (a) is sold to a third-party purchaser; or (b) is to become listed or quoted on an established securities market or exchange (for example, NASDAQ, NYSE) or becomes readily tradable on a secondary market (or the substantial equivalent thereof) (i.e., a “Public Event”).

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS


See our Business Plan, Stonebridge Valuation, Offering Memorandum, and Investor Presentation below:


Please contact your PathFree Expansion LLC representative to receive a complete investors package, including digital subscription documents with instructions and options for funding your investment.

Contact us with questions or inquiries at: 1 (888) 83-PATHFREE
Email us at: info@pathfree.com

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

This information is provided by PitchBook

US Market Insights Q1 2024

Q4 2023 Medtech Report

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

Please contact your PathFree Expansion LLC representative to receive a complete investors package, including digital subscription documents with instructions and options for funding your investment.
Contact Us with Questions or Inquiries at:

1 (888) 83-PATHFREE

Email us at: info@pathfree.com

Watch, Read, Listen

ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS

Translate »